Ling, G;
Nathwani, AC;
Tuddenham, EGD;
(2018)
Recent advances in developing specific therapies for haemophilia.
British Journal of Haematology
, 181
(2)
pp. 161-172.
10.1111/bjh.15084.
Preview |
Text
Ling_Recent_advances_haemophilia.pdf - Accepted Version Download (451kB) | Preview |
Abstract
Haemophilia therapy has undergone very rapid evolution in the last 10 years. The major limitation of current replacement therapy is the short half-life of factors VIII and IX. These half-lives have been extended by the addition of various moieties, allowing less frequent infusion regimens. Entirely novel approaches have also entered the clinic, including a bispecific antibody that mimics factor VIII and strategies that rebalance the haemostatic mechanism by reducing antithrombin through inhibition of synthesis. These two treatments are available by subcutaneous injection at infrequent intervals and both can be used in patients with neutralising antibodies (inhibitors). Finally, a cure may be on the horizon with preliminary evidence of success for gene therapy in haemophilia B and A.
Type: | Article |
---|---|
Title: | Recent advances in developing specific therapies for haemophilia |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1111/bjh.15084 |
Publisher version: | http://dx.doi.org/10.1111/bjh.15084 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | haemophilia, bleeding disorders, therapy, Factor VIII, Factor IX, gene therapy |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology |
URI: | https://discovery.ucl.ac.uk/id/eprint/10046534 |
Archive Staff Only
![]() |
View Item |